LAMOLINARA, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 3.226
AS - Asia 1.801
EU - Europa 1.570
Continente sconosciuto - Info sul continente non disponibili 331
SA - Sud America 254
AF - Africa 40
OC - Oceania 2
Totale 7.224
Nazione #
US - Stati Uniti d'America 3.131
SG - Singapore 806
IT - Italia 446
CN - Cina 425
IE - Irlanda 223
VN - Vietnam 210
BR - Brasile 198
RU - Federazione Russa 181
SE - Svezia 171
DE - Germania 116
UA - Ucraina 96
GB - Regno Unito 95
IN - India 89
TR - Turchia 80
FR - Francia 55
CA - Canada 52
HK - Hong Kong 48
BD - Bangladesh 46
FI - Finlandia 39
NL - Olanda 27
PL - Polonia 27
AR - Argentina 22
ZA - Sudafrica 20
MX - Messico 19
AT - Austria 18
BE - Belgio 16
IQ - Iraq 14
CZ - Repubblica Ceca 13
JP - Giappone 12
ES - Italia 10
CL - Cile 8
CO - Colombia 7
ID - Indonesia 7
PK - Pakistan 7
UZ - Uzbekistan 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
EC - Ecuador 5
IL - Israele 5
JM - Giamaica 5
KE - Kenya 5
KR - Corea 5
BG - Bulgaria 4
EG - Egitto 4
IR - Iran 4
JO - Giordania 4
MA - Marocco 4
NP - Nepal 4
OM - Oman 4
PH - Filippine 4
PT - Portogallo 4
RO - Romania 4
BZ - Belize 3
CH - Svizzera 3
HN - Honduras 3
MD - Moldavia 3
SA - Arabia Saudita 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CR - Costa Rica 2
EU - Europa 2
GR - Grecia 2
LB - Libano 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
PR - Porto Rico 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
PA - Panama 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 6.896
Città #
Singapore 642
San Jose 406
Chandler 369
Ashburn 232
Dublin 218
Jacksonville 160
Council Bluffs 154
Dearborn 124
Beijing 119
Ann Arbor 102
Dallas 99
Princeton 95
Santa Clara 85
Chieti 77
New York 71
Los Angeles 70
Ho Chi Minh City 63
The Dalles 51
Altamura 43
Nanjing 43
Hong Kong 41
Izmir 39
Hanoi 38
Boardman 35
Munich 35
Pescara 34
Wilmington 30
Redondo Beach 29
Rome 29
Montreal 26
Warsaw 23
Dong Ket 22
São Paulo 22
Buffalo 20
Moscow 20
Nanchang 20
Southend 20
Brooklyn 19
Orem 19
Cambridge 18
Chennai 17
Brussels 16
Columbus 16
Johannesburg 15
Woodbridge 15
St Louis 14
Frankfurt am Main 13
Lappeenranta 13
Nuremberg 13
Atlanta 12
Hefei 12
Phoenix 12
Poplar 12
Pune 12
Tokyo 12
Tongling 12
Washington 12
Amsterdam 11
Da Nang 11
Denver 11
Helsinki 11
Mexico City 11
Ankara 10
Camerino 10
Castignano 10
Chicago 10
Haiphong 10
Hebei 10
Kunming 10
Manchester 10
Milan 10
Verona 10
Vienna 10
Houston 9
London 9
Stockholm 9
Toronto 9
Ancona 8
Bologna 8
Brno 8
Seattle 8
Shenyang 8
Charlotte 7
Düsseldorf 7
L’Aquila 7
Napoli 7
San Mateo 7
Tianjin 7
Turku 7
Baghdad 6
Collecorvino 6
Jiaxing 6
Macerata 6
Rouen 6
Saint-Saens 6
San Francisco 6
Mumbai 5
Nairobi 5
Rio de Janeiro 5
Santiago 5
Totale 4.342
Nome #
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 203
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization 188
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 186
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 175
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice 172
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 163
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 159
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 158
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 157
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 154
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 154
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 147
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 145
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 141
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 141
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 135
Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer 134
Subretinal fluid levels of signal-transduction proteins and apoptosis molecules in macula-off retinal detachment undergoing scleral buckle surgery 134
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 132
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 131
Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema 131
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 130
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 130
Effects of GHRH Deficiency and GHRH Antagonism on Emotional Disorders in Mice 126
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 125
Effects of mesenchymal stromal cells and human recombinant Nerve Growth Factor delivered by bioengineered human corneal lenticule on an innovative model of diabetic retinopathy 120
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized Balb/c mice. 120
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 120
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 117
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 115
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 113
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 112
Multiorgan Metastasis of Human HER-2(+) Breast Cancer in Rag2(-/-);Il2rg(-/-) Mice and Treatment with PI3K Inhibitor. 109
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages 107
Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma 106
Deciphering the state of immune silence in fatal COVID-19 patients 106
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis 106
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 105
Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1 104
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 103
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment 103
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 102
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 101
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 100
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer 99
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma 98
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 97
Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S-Methyl-DM4 94
Natural compounds, antioxidant, and antiandrogens in the prevention of prostate cancer: in vivo evidences from murine models and human clinical studies. 90
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 84
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction 81
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer 81
The specific deletion of cyclooxygenase-1 in megakaryocytes/platelets reduces intestinal polyposis in ApcMin/+ mice 80
Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors 79
Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance 78
Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid Anabolism 76
Independent prognostic and predictive role of interstitial macrophages in kidney biopsies of IgA nephropathy patients 72
Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study 71
Duality of Nrf2 in iron-overload cardiomyopathy 63
IL-7 promotes the formation of DNA double strand breaks and DNA repair in murine pro-B cells 56
null 52
Feasibility Study of Decellularized Corneal Lenticule in a Porcine Model for Macular Hole Closure 25
Liver-specific BAG3 knockout delays chemically induced hepatocellular carcinoma development 12
Systemic AAV8-SIL1-TAT therapy improves motor function in a mouse model of Marinesco-Sjögren syndrome 8
Targeting CDK4/6 in Combination with Phage-Based Anti-HER2 Vaccination Overcomes Immune Evasion and Enhances the Anticancer Response in Breast Cancer 4
Tumor microenvironment remodeling by STING agonism sensitizes endothelial cells to cytotoxic anti-PD-L1/L2 antibody 4
Totale 7.224
Categoria #
all - tutte 30.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022275 0 0 6 63 12 3 8 29 19 11 26 98
2022/2023931 75 137 69 111 85 155 41 77 106 8 35 32
2023/2024448 30 22 28 23 26 132 95 24 8 16 4 40
2024/20251.268 58 262 209 56 33 69 58 91 117 69 144 102
2025/20262.752 182 84 218 324 333 178 485 117 262 286 160 123
2026/2027254 65 130 59 0 0 0 0 0 0 0 0 0
Totale 7.224